Science Communication
for BioTech, ClimateTech & The Blue Economy
Translating complex R&D, clinical data, and marine science into high-converting commercial assets.
I help growth-stage startups bridge the gap between the lab and global markets -transforming dense research into investment-ready White Papers, strategic One-Pagers, and authoritative thought leadership that drives funding.
Services
Executive White Papers & Reports
Turning Complex R&D into Market Authority
Translating dense biological, environmental, and tech data into high-converting White Papers and Executive Briefs. Designed to position BioTech and ClimateTech ventures as category leaders for VCs, corporate partners, and decision-makers
Deliverables:
- Commercial White Papers
- Deep-Dive Technical Reports
- Industry Trend Analyses
Investor Assets & One-Pagers
Translating Hard Science into Investment Valuation
Bridging the gap between R&D milestones and VC criteria. Turning scientific breakthroughs into sharp, high-impact investor assets that clearly demonstrate market viability, scalability, and ROI.
Deliverables:
- Executive One-Pagers
- Investor Newsletters & Updates
- Scientific Due Diligence Summaries
- R&D Pitch Deck Briefs
Authority & Thought Leadership Content
Driving Organic Inbound Interest & Credibility
Transforming technical insights into high-engagement content for executives and company channels. Building long-term digital authority that attracts investors, talent, and strategic B2B leads
Deliverables:
- Executive LinkedIn Content
- Website Knowledge Hub Articles
- Case Study Summaries
Portfolio
Oceanic Bio-Shield
A comprehensive analysis of sulfated polysaccharides’ role in modern antiviral therapy. This white paper bridges complex marine biochemistry with clinical development pathways, adhering to GCP standards. It translates early-stage biochemical research into actionable market potential and de-risked investment thesis for BioTech stakeholders.
Translating Academic Biotech for B2B Audiences
A real-world example from a recent Nature Biotechnology study on marine bacteria engineered for carbon removal:
– Academic text: “We engineered the marine bacterium Alteromonas macleodii for enhanced siderophore production, conferring a 2.6-fold increase in the rate of olivine dissolution…”
– Commercial & investor-ready translation: “By engineering marine bacteria, we sped up rock dissolution by 260% – turning a slow natural process into a fast, commercially viable operation.”
Can AI-Powered Aquaculture Save the World’s Fish?
Global seafood consumption has risen by 128% since the 1960s, creating pressure on wild fish stocks and marine ecosystems. Aquaculture – farming fish, shellfish, and seaweed – offers a sustainable alternative to overfishing by producing seafood under controlled conditions.
About
Hi, I’m Noa Gonen. I help growth-stage BioTech, ClimateTech, and Ocean-Tech ventures turn complex scientific R&D into high-converting commercial assets.
With a B.Sc. in Marine Biology and background in regulatory-aligned communications, I bridge the gap between dense scientific data and market valuation. I translate breakthrough research, environmental data, and technical methodologies into authoritative White Papers, Executive One-Pagers, and Thought Leadership content designed for VCs, institutional investors, and strategic partners.